Dassault Systèmes SE Aktie
34,62 €
Deine Einschätzung
Dassault Systèmes SE Aktie
Was spricht für und gegen Dassault Systèmes SE in den nächsten Jahren?
Pro
Kontra
Rendite von Dassault Systèmes SE im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Dassault Systèmes SE | 0,12 % | -2,01 % | -7,29 % | -15,17 % | -22,00 % | -16,43 % | 19,45 % |
Cap Gemini S.A. | 0,08 % | 0,66 % | 2,19 % | 9,85 % | 0,63 % | 15,91 % | 73,94 % |
CrowdStrike Holdings Inc | -0,20 % | -0,68 % | 23,99 % | 166,27 % | 55,32 % | 68,38 % | - |
Gartner Inc. | -1,17 % | -2,14 % | 6,20 % | 27,97 % | 0,49 % | 92,01 % | - |
Kommentare
News
Dassault Systèmes and Mistral AI Partner to Offer Trusted, AI-Powered Industry-Grade Solutions to Accelerate the Generative Economy
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Mistral AI today announced their partnership to bring the full power of frontier AI to industries in a trusted environment.
For more
Dassault Systèmes’ 3DEXPERIENCE Platform on the Cloud Selected by Mahindra & Mahindra as It Accelerates Its Digital Transformation
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Mahindra & Mahindra, a leader in automotive, farm and services businesses in India, is advancing its digital
Medidata Launches Clinical Data Studio, Leveraging AI to Modernize the Data Experience in Clinical Trials
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Clinical Data Studio, a unified experience